The hybrid capture II (HCII) ... The samples are classed as positive for HPV DNA if their RLU is over 1.0, which is equivalent to 1 pg of HPV DNA per ml. In conclusion, ...

Circulating HPV DNA levels post-CCRT were correlated to disease response (PET-CT). In pre-CCRT plasma, HPV-detect demonstrated 100% sensitivity and 93% specificity, ...

High-risk HPV DNA is detected in more than 99% of cervical carcinoma worldwide. HPV testing can improve cervical cancer screening and has different applications: - As primary screening ...

The study shows how an HPV DNA test, which is cheaper than many current screening options, could make cervical cancer screening more accessible to women in countries with fewer resources.

HealthDay News — A baseline negative human papillomavirus (HPV) DNA test provides greater reassurance against invasive cervical intraepithelial neoplasia grade 3 (CIN3) at 18-year follow-up than ...

Circulating tumor tissue-modified viral HPV DNA detected through a new assay appeared associated with nodal disease burden among patients with HPV-positive oropharyngeal squamous cell carcinoma ...

Testing cervical specimens for DNA of oncogenic (high-risk) types of human papillomavirus (HPV), the causal agents of cervical cancer, has entered clinical practice, but this test is used mainly ...

According to a 2014 survey, some 9.4 percent of cervical cancers are unrelated to HPV, while 3.2 percent are caused by rare types of HPV that aren’t detected by the test.

HPV-positive circulating tumor (ct)DNA after chemoradiation (CRT) for cervical cancer had an independent association with worse outcomes, suggesting potential as a biomarker to guide decision ...

FDA Approves HPV DNA Test That Can Replace Pap Smears. What it really means for your next trip to the gyno . by Casey Gueren Published: Apr 25, 2014 3:14 PM EDT. Save Article.